Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2012
12/05/2012CN102812038A Treatments For Gastrointestinal Disorders
12/05/2012CN102811782A 免疫球蛋白G Fc区结合多肽 Immunoglobulin G Fc region binding polypeptides
12/05/2012CN102811744A Chemically Modified Cell-penetrating Peptides For Improved Delivery Of Gene Modulating Compounds
12/05/2012CN102811735A Variants Of The Group-6 Allergens Of The Poaceae With Reduced Allergenicity By Mutagenesis Of Proline Residues
12/05/2012CN102811733A Bacteremia-associated Antigen From Staphylococcus Aureus
12/05/2012CN102811704A Method of use of stabilized plant-derived growth factor in skin care
12/05/2012CN102807980A Classical swine fever antibody PPA-ELISA detection kit and preparation method thereof
12/05/2012CN102807616A Novel method for preparing gonyatoxin GTX2 and GTX3 artificial antigens
12/05/2012CN102807615A Method for synthesizing single succinyl acyl oxygen deltamethrin hapten
12/05/2012CN102807614A Hapten synthesis method of pyrethroids alpha-carboxy ethyl sulfur formyl deltamethrin
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807612A Polypeptide fragment and preparation method and application thereof
12/05/2012CN102807611A Streptococcus pneumonia PiuA protein fragment and preparation method thereof
12/05/2012CN102807610A Antibacterial peptides and application of antibacterial peptides to preparation of medicament resisting drug-resistant bacteria
12/05/2012CN102807609A Polypeptide for preventing and/or treating pain and application of polypeptide
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102807488A Hapten and antigen universally used for ether pyrethroid pesticide, and synthesis method and application of hapten and antigen
12/05/2012CN102321602B Applications of beta-lactamase in improving functional protein folding and preparation of fusion protein
12/05/2012CN102191241B Engineering bacteria capable of producing fatty acid, and preparation method and application thereof
12/05/2012CN101974072B Escherichia coli TolC antigen as well as antibody and application thereof
12/05/2012CN101948526B Method for separating and purifying pulmonary alveoli surface active proteins (SP-B and SP-C)
12/05/2012CN101885760B HIV-1gp120 gene consensus sequence optimized by codon and gp120 nucleic acid vaccine
12/05/2012CN101885757B Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
12/05/2012CN101631800B Canine thymic stromal lymphopoietin protein and uses thereof
12/05/2012CN101531709B Method for cutting Yersinia pestis F1 antigen and relative application thereof
12/05/2012CN101495636B DNA vaccine for koi herpes virus (KHV) disease
12/05/2012CN101386641B Synthetic peptide vaccines for foot-and-mouth disease
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101336299B Angiogenic tyrosyl tRNA synthetase compositions and methods
12/05/2012CN101243177B L-amino acid-producing microorganism and method for producing L-amino acid
12/05/2012CN101189261B High affinity melan-A t cell receptors
12/05/2012CN101133158B 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use
12/05/2012CN101061136B Immunity therapeutic preparation with interleukin-2 neutralizing function
12/04/2012US8324482 Transgenic plants
12/04/2012US8324470 Soybean cultivar 04334045
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324363 Microarray for detection of the deletion of exon 3 of the G-CSF gene
12/04/2012US8324362 Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
12/04/2012US8324354 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
12/04/2012US8324349 Process for obtaining botulinum neurotoxin
12/04/2012US8324346 Bioactive keratin peptides
12/04/2012US8324172 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
12/04/2012US8324170 Interferon gamma receptor beta chain compositions and methods of inhibiting apoptosis
12/04/2012US8324169 VEGF-activated ligands
12/04/2012US8324168 Methods for treating pain
12/04/2012US8324164 Peptides and altered peptide ligands derived from HSP60 and pharmaceutical compositions
12/04/2012US8324163 Methods for treating reperfusion injuries using flagellin
12/04/2012US8324162 Diuretic and natriuretic polypeptides lacking the blood pressure lowering property
12/04/2012US8324160 Chimeric polypeptides and uses thereof
12/04/2012US8324158 Methods for inhibiting CLC-2 channel with GATX2
12/04/2012US8324153 Antiviral cell-penetrating peptides
12/04/2012US8324152 Composition for the treatment of atherosclerosis
12/04/2012US8324151 Treatment of sepsis and septic shock using ghrelin and growth hormone
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012US8323987 Modulation of epidermal growth factor heterodimer activity
12/04/2012US8323964 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323961 HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
12/04/2012US8323917 Method of screening for compounds that inhibit the enzymatic activity of GWT1 gene product
12/04/2012US8323916 Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L
12/04/2012US8323913 Marker for inflammatory conditions
12/04/2012US8323912 Methods of screening heteromeric T1R2/T1R3 receptors which modulate sweet taste signaling
12/04/2012US8323885 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders
12/04/2012US8323884 Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses
12/04/2012US8323667 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
12/04/2012US8323660 Method for identification, isolation and production of antigens to a specific pathogen
12/04/2012US8323658 Infectious bursal disease virus antigenic isolates and vaccines
12/04/2012US8323655 Identification of antigenic peptides from multiple myeloma cells
12/04/2012US8323636 Long-acting interferons and derivatives thereof and methods thereof
12/04/2012US8323635 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/04/2012US8323634 Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor
12/04/2012CA2629304C Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination
12/04/2012CA2443345C Disease-associated protein
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2340304C Multicomponent vaccines
12/04/2012CA2241267C Improved methods for transforming phaffia strains, transformed phaffia strains so obtained and recombinant dna in said methods
12/04/2012CA2222509C Connective tissue growth factor
11/2012
11/29/2012WO2012162611A1 Simukunin
11/29/2012WO2012162534A2 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012WO2012162368A1 Expression of caleosin in recombinant oleaginous microorganisms to increase oil content therein
11/29/2012WO2012162179A1 Tau protease compositions and methods of use
11/29/2012WO2012162162A1 Pigment structures, pigment granules, pigment proteins, and uses thereof
11/29/2012WO2012162137A1 Hepatitis c virus particles, vaccines, compositions and methods related thereto
11/29/2012WO2012161982A1 Chloroplast transit peptides and methods of their use
11/29/2012WO2012161112A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
11/29/2012WO2012160565A1 Biomolecular electronic device and process of use
11/29/2012WO2012160345A1 Pathogenic bacteria
11/29/2012WO2012160333A2 Recombinant yeast
11/29/2012WO2012160278A1 Universal primers and the use thereof for the detection and identification of amphibia/fish species
11/29/2012WO2012160127A1 Method for the diagnosis of rheumatoid arthritis
11/29/2012WO2012160027A1 Recombinant expression of soluble interferon
11/29/2012WO2012159891A1 Endosperm-specific plant promoters and uses therefor
11/29/2012WO2012159836A1 New chymase binding compounds and medical uses thereof
11/29/2012WO2012159782A1 High affinity sumo traps
11/29/2012WO2012159754A2 Individualized vaccines for cancer
11/29/2012WO2012159643A1 Individualized vaccines for cancer
11/29/2012WO2012159638A1 Non-cytotoxic alpha viral construct, cell line and composition and a method for the assessment of the effect of antiviral agents.
11/29/2012WO2012159562A1 Truncated human papillomavirus type 33 protein l1